Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy

BJU International

Volumn 88, Issue 1, 2001, Pages 58-62

  Baniel, J ^b   Israilov, S ^a   Segenreich, E ^b   Livne, P M ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Erectile dysfunction; Intracorporal injection; Progressive treatment; Radical prostatectomy; Sildenafil; Vacuum device

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; SILDENAFIL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DRUG EFFICACY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; HUMANS; IMPOTENCE; INJECTIONS; MALE; MIDDLE AGED; PAPAVERINE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POSTOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT FAILURE; URINATION DISORDERS; VACUUM; VASODILATOR AGENTS;

EID: 0035729964     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.02254.x     Document Type: Article

References (27)

1. Diagnosis of prostatic carcinoma: The yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography
2. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate
3. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve sparing technique
4. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspective
5. Neoadjuvant hormonal therapy in carcinoma of the prostate
6. Quality of life 12 months after radical prostatectomy
7. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids
8. Patient-reported complications and follow-up treatment after radical prostatectomy
9. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life
10. Impotence following radical prostatectomy: Insight into etiology and prevention
11. Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients
12. Use of sildenafil (Viagra) in patients with cardiovascular disease
13. Conservation of inflatable penile prosthesis during radical prostatectomy
14. Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: Initial results in 50 patients
15. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
16. Role of Viagra after radical prostatectomy
17. Sildenafil citrate (Viagra) after radical prostatectomy
18. Vacuum constriction device for management of erectile impotence
19. Treating erectile dysfunction with a vacuum tumescence device: A retrospective analysis of acceptance and satisfaction
20. Vacuum devices in erectile dysfunction: Indications and efficacy
21. Patient satisfaction with pharmacological erection program
22. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: A clinical double-blind study
23. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy
24. The use of a vacuum constrictor device to augment a partial erection following an intracavernous injection
25. Vacuum tumescence devices: The role of papaverine in the selection of patients
26. Combining intracavernous injection and external vacuum as treatment for erectile dysfunction